|
|
1.
|
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. MedStar authors:
Year: 2021
Citation: - Nature Medicine. 27(10):1818-1824, 2021 10.
Department: - MedStar Heart and Vascular Institute
Medline publication type:
All authors: - Axelsson A, Bach RG, Becker JR, Benson L, Braunwald , Bundgaard H, Burns KM, Canter C, Cirino AL, Colan SD, Day SM, Ho CY, Lakdawala NK, Lever HM, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Patel AR, Pereira AC, Rossano JW, Russell MW, Seidman CE, Solomon SD, Soslow JH, Taylor MRG, Thrush P, VANISH Investigators, Vargas JD, Wheeler MT, Wilmot I, Zahka K
|
|
|
2.
|
Developing New Treatments for Heart Failure: Focus on the Heart. MedStar authors:
Year: 2016
Citation: - Circulation: Heart Failure. 9(5), 2016 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Butler J, Carr J, Cleland JG, Colucci WS, Crandall D, Deckelbaum LI, Dinh W, Dunnmon P, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Krahn T, Kramer F, Larson CJ, Okada S, Parsey RV, Sabbah HN, Senni M, Shah SJ, Sikora S, Stockbridge N, Wahlander K
|
